Global Cancer Tissue Diagnostics Market Poised for Strong Growth at a CAGR of 8.3% through 2026

In recent years, rising prevalence of cancer coupled with growing demand for personalized medicine are anticipated to propel the growth of the tissue diagnostic market. Also, growing awareness about tissue diagnosis in emerging economies is expected to act as the most prominent factors behind the growth of this market. Considering these factors, Market Research Reports Search Engine (MRRSE) has been recently included a new report titled “Cancer Tissue Diagnostics Market: Global Industry Analysis and Opportunity Assessment 2016-2026” to its vast repository. This intelligent study includes data related to the current as well as future market status, with a keen focus on prime market drivers and opportunities.

Request for sample report: http://www.mrrse.com/sample/3306

According to the study key findings, the global cancer tissue diagnostics market is poised to register a CAGR of 8.3% over the forecast period. Growing at this pace, the market will become worth close to US$ 4,350 Mn in 2016 to nearly US$ 9,650 Mn by 2026 end. At present, the number of biomarkers that can be utilized for early cancer detection from blood or plasma samples are constantly increasing, which is expected to bring new cancer biomarker tests in the market in the near future, which as a result propelling the growth of cancer tissue diagnostics market.

Tissue diagnostics are important diagnostic techniques mainly used for diagnosis and management of cancer. Initially, the report starts with an executive summary that gives a concise overview of the cancer tissue diagnostics market along with key market segment and regions. The section of the report is devoted to explaining the market definitions of the cancer tissue diagnostics market by various types of cancer treatment detection.

Different cancer types considered in the scope of the global cancer tissue diagnostics market report include breast cancer, lung cancer, colorectal cancer, melanoma, blood cancers (Hodgkin & non-Hodgkin lymphoma, leukemia, myeloma etc.), prostate cancer, ovarian cancer, stomach cancer and liver cancer. On the other hand, Hospitals, research laboratories, ambulatory surgical centers (ASCs), and diagnostic centers are the prime end users of tissue diagnostic products and services.

The geographical bifurcation includes North America, Asia Pacific, Middle East and Africa, Europe and Latin America as the prime regions for assessing the market size. In terms of geography, North America has dominated the global cancer tissue diagnostics market in revenue terms in 2016, and this trend is projected to continue throughout the forecast period. Moreover, the research highlights various key dynamics supporting the growth of the market. It has been analyzed that meeting the needs of hospital laboratories presents a significant opportunity for the growth of the global cancer tissue diagnostics market.

Further, a section covering detailed competitive landscape of the cancer tissue diagnostics market has been highlighted. This section comprises company profile including overview, financials, strategy, recent developments of leading players, which are Bio Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Abcam plc., Abbott Laboratories, ROSETTA GENOMICS, Creative- Biolabs, Sigma-Aldrich Co. LLC and others.

Browse Full Report with TOC : http://www.mrrse.com/cancer-tissue-diagnostics-market

About Us
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street
Suite 700
Albany, NY - 12207
United States
Telephone: +1-518-730-0559
Email: sales@mrrse.com
Website: http://www.mrrse.com/

This release was published on openPR.